As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Investing.com -- Shares of Novo Nordisk (NYSE: NVO) fell 3.6% on Friday after the U.S. Department of Health and Human ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.

President Donald Trump’s first moves on Medicaid and the Affordable Care Act signal his administration’s willingness to make major changes to the government programs.

1. Mr. Trump announced in November 2024 that Robert F. Kennedy Jr., son of former Attorney General Robert F. Kennedy and nephew to President John F. Kennedy, is his pick for HHS Secretary. Mr. Kennedy ...